Compare Cloudflare Inc (NET) vs TransMedics Group Inc (TMDX) Price & Performance

Cloudflare (NET) trades at $314.30, up 1.26% today and near its 52-week high, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth, with Q2 2026 sales up 36% year-over-year to $696.1 million, and has beaten EPS estimates for three consecutive quarters. However, it remains unprofitable with a net income margin of -8.21% and carries a premium valuation with a P/S ratio of 42.99.

The investment case hinges on Cloudflare's leadership in cloud security and AI-driven demand, but high valuation and persistent losses pose risks. Analyst consensus is bullish with a $337.10 price target, though competitive pressures and execution challenges could impact growth.

TransMedics Group (TMDX) trades at $86.43, down 2.24% amid recent earnings misses but maintains strong analyst support with a $99.57 consensus target. The stock shows bullish technical signals with support at $84-87, though RSI levels suggest overbought conditions. Fundamentally, the company demonstrates robust profitability with 58.69% gross margins and 22.69% net income margins, despite recent quarterly earnings falling short of expectations.

Investment outlook remains positive given strong institutional backing and growth potential in organ transplant technology, though risks include ongoing fiduciary investigations and margin pressure from increased operating costs. The stock offers 15% upside to consensus targets but requires monitoring of Q3 earnings performance and legal developments.